Dillon & Associates Inc
- SEC CIK
- 0001054425
- Latest filing
- Aug 5, 2026
PCRX holding history
Pacira BioSciences, Inc. in every 13F filed by Dillon & Associates Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PCRX overviewAll 13F holders of PCRXFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −7,749−100.0% | Sold out | Holders |
| Q3 2023 | 7,749 | $240.0K | <0.1% | −7,204−48.2% | Reduced | Holders |
| Q2 2023 | 14,953 | $598.0K | 0.1% | −26,735−64.1% | Reduced | Holders |
| Q1 2023 | 41,688 | $1.71M | 0.3% | −230−0.5% | Reduced | Holders |
| Q4 2022 | 41,918 | $1.64M | 0.4% | −1,460−3.4% | Reduced | Holders |
| Q3 2022 | 43,378 | $2.30M | 0.5% | +11,534+36.2% | Added | Holders |
| Q2 2022 | 31,844 | $1.85M | 0.4% | +28,759+932.2% | Added | Holders |
| Q1 2022 | 3,085 | $234.0K | <0.1% | +3,085 | New | Holders |